Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis presenting as a relapsing amnestic syndrome.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Advances in the management of MS symptoms: real-life evidence.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
[Treatment of relapses of multiple sclerosis (a review)].
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Neurobehavioral disorders.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.

Pages